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On 1 February, 2016, the World Health Organization´s (WHO) 
Director-General declared that the Zika virus epidemic in the 
Americas is a Public Health Emergency of International 
Concern (PHEIC). The illness caused by this virus is very 
rarely fatal, and it causes mild symptoms: rash, headaches, 
conjunctivitis, sometimes fever and joint pains. Besides, an 
estimated 80% of cases are asymptomatic, which makes it 
next to impossible to establish an exact number of infected 
persons. The reason for declaring this event as a PHEIC was 
not grounded on the severity of the disease in terms of 
fatalities. Rather, the major source of concern was the then-
suspected link between Zika virus and a surge in cases of 
microcephaly and a danger of developing Guillain-Barré 
syndrome.
This has been the fourth time this legal figure is employed to 
address an issue related to the international spread of an 
infectious disease. Article 12 of the International Health 
Regulations (IHR) of 2005 contemplates the possibility of the 
WHO’s Director-General declaring a PHEIC. As a procedural 
requirement for doing so, an Emergency Committee 
composed of experts needs to be summoned, according to 
articles 48 & 49 of the IHR. Every PHEIC has had its own 
particular features, both from a medical and an institutional-
legal perspective. The declaration of Zika as a PHEIC further 
shapes the understanding of why and how this figure is 
employed by WHO officials. It does not adopt a rigid and 
restrictive approach towards which type of diseases warrant 
declaring a PHEIC, rather leaving this for case-by-case 
assessments. Therefore, in order to further grasp the broad 
nature of this legal figure, a brief overview of each PHEIC so 
far can be useful for understanding some elements that 
might be shared, and others that are contrasted between 
them.
Enter the IHR: The 2009-2010 H1N1 Influenza Pandemic
On 25 April, 2009, the Director-General of the WHO 
declared, for the first time, that the unusual cases of A(H1N1) 
influenza reported by Mexico and the United States 
constituted a PHEIC. Later, on June 11th, 2009, there was also 
a declaration of the highest pandemic alert level (then level 
6), which led to criticisms from other countries that were not 
as affected by the virus as Mexico and the United States. The 
main argument was that pharmaceutical companies made 
huge profits (as they usually do) due to the declaration of a 
pandemic.
The backlash against the WHO resulted, among other things, 
in an investigation within the Council of Europe due to what 
was perceived as undue influence by the pharmaceutical 
industry. Although the eventual report presented at the 
Parliamentary Assembly of the Council did not find evidence 
of malfeasance, it did include criticism related to lackluster 
transparency in decision-making. Not disclosing the names 
of members of the Emergency Committee, which falls under 
the discretion of the WHO Director-General since there is no 
explicit legal provision in the IHR mandating it, also added 
fuel to the fire.
After the 2009-2010 influenza pandemic, an extensive report 
by an IHR Review Committee was issued. It contained, inter 
alia, several recommendations for enhancing decision-
making within the WHO. However, there were no calls for a 
reform of any of the provisions within the IHR.
The push against Poliomyelitis
On 5 May, 2014, a PHEIC was declared for the second time, in 
relation to the spread of wild poliovirus throughout regions 
of Africa and the Middle East. This was seen as the 
consequence of both an anti-vaccination sentiment, as well 
as longstanding military conflict that dramatically 
undermined the provision of health services throughout 
these regions.
The wild poliovirus PHEIC declaration can be seen as a 
companion to the decades-old global polio eradication 
campaign. This way, it would serve as a catalyst for this goal, 
and not just as a reaction to a new event.
As the objective of full polio eradication is increasingly closer 
to being in sight, the justification for using the legal figure of 
a PHEIC for this purpose constitutes a precedent for 
expanding its scope. This can make the figure more flexible in 
order to deal with different types of challenges.
Deadly delay: The Ebola outbreak in West Africa
Despite initial reports in March 2014 by Médécins Sans 
Frontières about the out-of-control spread of Ebola virus 
throughout Guinea, a PHEIC was only declared on 8 August
of the same year. The WHO was then criticized for the 
opposite reason than during the H1N1 influenza pandemic: In 
this case, it was chastised for not raising the alarm fast 
enough. While this is a difficult argument to make due to the 
issue of causality, it is believed that had this alarm been 
raised before, more resources could have been directed 
earlier for containing the spread of Ebola.
In September 2014 the United Nations Mission for Ebola 
Emergency Response (UNMEER) was created as an ad hoc 
organism to aid in the fight against Ebola. This was also seen 
as a sign of the lack of capacity by the WHO. In turn, the 
overall performance of UNMEER was itself the object of 
criticism as well.
The worst of the West African Ebola crisis seems to be over. 
The WHO Director-General declared the Ebola PHEIC as 
formally terminated, although the disease was still present in 
some regions. Proposals by an IHR External Review 
Committee on how to reform disease outbreaks decision-
making within the WHO are scheduled for discussion at the 
upcoming 69  World Health Assembly in Geneva. Unlike in 
the aftermath of the 2009 A(H1N1) influenza pandemic, it 
might actually include modifying certain provisions of the 
IHR.
Other, more detailed posts about the Ebola crisis in West 
Africa can be accessed here and here.
The race for knowledge: The Zika emergency of 2016
th
The most recent use of a PHEIC by the WHO has been in the 
ongoing Zika epidemic that started ravaging the Americas 
and the Caribbean, and is spreading beyond. Some believe 
that, unlike in the case of Ebola, the WHO’s regional body for 
the Americas, the Pan-American Health Organization, has 
been able to respond more effectively to the emergency.
Resources have been deployed in order to conduct research 
in the most affected countries, which led to producing 
evidence supporting the link between Zika and microcephaly. 
Other legal debates are already in motion, such as the limits 
of women’s sexual and reproductive rights in Latin America. 
Similarly, possible sanitation measures by health authorities
aimed at vector (mosquito) control are also the source of 
disagreements by commentators.
The criterion for assessing the justification for the 
declaration of a Public Health Emergency of International 
Concern is different for Zika virus than for previous 
instances. According to Annex 2 of the IHR, uncertainty can 
also be used as a legal argument for declaring a PHEIC. As 
members of this Emergency Committee stated, the Zika 
PHEIC Declaration was not made based upon what was 
known at the time, but rather because of what was not 
known.
With the shadow of the Ebola crisis still looming large over 
the WHO as an institution, its actions in the recent Zika crisis 
can also be construed as a reaction to this pressure. One 
could argue it was too risky for the WHO to wait until sound 
scientific evidence is available before reacting: Had the WHO 
neglected to respond to initial reports of the surge in Zika 
and microcephaly cases, the posterior discovery of this link 
would have been yet another blow to its institutional 
reputation.
The legal framing of PHEICs can be construed as granting 
this leeway. One of the main reasons for the obsolescence of 
the 1969 version of the IHR was its rigid approach towards 
diseases, which left new and reemerging pathogens out of its 
purview. Given how uncertainty is a constant factor at stake 
when making these decisions, it is understandable to adopt 
this broad approach. Of course, as shown by the backlash in 
previous PHEIC declarations, this does not mean the WHO 
has a “blank check”. The conundrum is still how to draw a 
clear line between over- and underreacting. This is prima 
facie a technical-medical assessment, but, in fact, it acquires 
a legal dimension at the same time.
In sum, a broader vision containing the previous PHEIC 
declarations provides insights on the WHO’s response to the 
current Zika epidemic. Their similarities and differences can 
be appraised for grasping how wide this figure can be. 
Analyzing whether declaring a PHEIC is legally justified 
requires case-by-case assessments. The complexities of 
every communicable disease outbreak imply that a definite, 
“one-size-fits-all” legal category is a longshot.
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